Summary
Historically, protection against virus infections has relied on the use of vaccines, but the induction of an immune response requires several days and in certain situations, like in newborn animals that may be infected at birth and die in a few days, there is not sufficient time to elicit a protective immune response. Immediate protection in new born could be provided either by vectors that express virus-interfering molecules in a tissue specific form, or by the production of animals expressing resistance to virus replication. The mucosal surface is the largest body surface susceptible to virus infection that can serve for virus entry. Then, it is of high interest to develop strategies to prevent infections of these areas. Virus growth can be interfered intracellularly, extracellularly or both. The antibodies neutralize virus intra- and extracellularly and their molecular biology is well known. In addition, antibodies efficiently neutralize viruses in the mucosal areas. The autonomy of antibody molecules in virus neutralization makes them functional in cells different from those that produce the antibodies and in the extracellular medium. These properties have identified antibodies as very useful molecules to be expressed by vectors or in transgenic animals to provide resistance to virus infection. A similar role could be played by antimicrobial peptides in the case of bacteria. Intracellular interference with virus growth (intracellular immunity) can be mediated by molecules of very different nature: (i) full length or single chain antibodies; (ii) mutant viral proteins that strongly interfere with the replication of the wild type virus (dominant-negative mutants); (iii) antisense RNA and ribozyme sequences; and (iv) the product of antiviral genes such as the Mx proteins. All these molecules inhibiting virus replication may be used to obtain transgenic animals with resistance to viral infection built in their genomes.
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Ahmad, I., W.R. Perkins, D.M. Lupan, M.E. Selsted, and A.S. Janoff. 1995. Liposomal entrapment of the neu-trophil-derived peptide indolicidin endows it with in vivo anti-fungal activity. Biochi. Biophy. Acta. 1237:109–114.
Anton, I.M., C. Suñé, R.H. Meloen, F. Borrás-Cuesta, and L. Enjuanes. 1995. A transmissible gastroenteritis coronavirus nucleoprotein epitope elicits T helper cells that collaborate in the in vitro antibody synthesis to the three major structural viral proteins. Virology. 212:746–751.
Baghian, A., J. Jaynes, F. Enright, and K.G. Kousolas. 1997. An amphipathic alpha-helical synthetic peptide analogue of melittin inhibits herpes simplex virus-I (HSV-l)-induced cell fusion and virus spread. Peptides. 18:177–183.
Ballesteros, M.L., C.M. Sanchez, and L. Enjuanes. 1997. Two amino acid changes at the N-terminus of transmissible gastroenteritis coronavirus spike protein result in the loss of enteric tropism. Virology. 227:378–388.
Bazzo, R., M.J. Tappin, A. Pastore, T.S. Harvey, J.A. Carver, and I.D. Campbell. 1988. The structure of melittin. A 1H-NMR study in methanol. Eur. J. Biochem. 173:139–146.
Bevins, C.L. and M. Zasloff. 1990. Peptides from frog skin. Annu. Rev. Bioch. 59:395–414.
Biocca, S. and A. Cattaneo. 1995. Intracellular immunization: antibody targeting to subcellular compartments. Trends Cell Biol. 5:248–252.
Biocca, S., M.S. Neuberger, and A. Cattaneo. 1990. Expression and targeting of intracellular antibodies in mammalian cells. EMBO J. 9:101–108.
Boman, H.G. 1991. Antibacterial peptides: key components needed in immunity. Cell. 65:205–207.
Bonifer, C., M. Vidal, F. Grosveld, and A.E. Sippel. 1990. Tissue specific and protein position independent expression of the complete gene domain for chicken lysozyme in transgenic mice. EMBO J. 9:2843–2848.
Brem, G., B. Brenig, H.M. Goodman, R.C. Seiden, F. Graf, B. Kruff, K. Springman, J. Hondele, J. Meyer, E.-L. Winnaker, and H. Krausslich. 1985. Production of transgenic mice, rabbits, and pigs by micro-injection into pronuclei. Zuchthygiene. 20:251–252.
Brem, G. and M. Muller. 1994. Large transgenic animals. In Animals with novel genes. N. Maclean, editor. Cambridge University Press, Cambridge. 179–244.
Brim, T.A., J.L. VanCott, J.K. Lunney, and L.J. Saif. 1994. Lymphocyte proliferation responses of pigs inoculated with transmissible gastroenteritis virus or porcine respiratory coronavirus. Am. J. Vet. Res. 55:494–501.
Castilla, J., B. Pintado, I. Sola, J.M. Sánchez-Morgado, and L. Enjuanes. 1998. Engineering passive immunity in transgenic mice secreting virus-neutralizing antibodies in milk. Nature Biotech. 16:349–354.
Castilla, J., I. Sola, and L. Enjuanes. 1997. Interference of coronavirus infection by expression of immunoglob-ulin G (IgG) or IgA virus-neutralizing antibodies. J. Virol. 71:5251–5258.
Chen, S.Y., J. Bagley, and W.A. Marasco. 1994. Intracellular antibodies as a new class of therapeutic molecules for gene therapy. Human Gene Therapy. 5:595–601.
Delmas, B., D. Rasschaert, M. Godet, J. Gelfi, and H. Laude. 1990. Four major antigenic sites of the coronavirus transmissible gastroenteritis virus are located on the amino-terminal half of spike glycoprotein S.J. Gen. Virol. 71:1313–1323.
Diamond, G., M. Zasloff, H. Eck, M. Brasseur, W.L. Maloy, and C.L. Bevins. 1991. Trachéal antimicrobial peptide, a cysteine-rich peptide from mammalian trachéal mucosa: peptide isolation and cloning of a cDNA. Proc. Natl. Acad. Sci. USA. 88:3952–3956.
Dobrovolsky, V.N., O.V. Lagutin, T.V. Vinogradova, I.S. Frolova, V.P. Kuznetsov, and O.A. Larionov. 1993. Human gamma-interferon expression in the mammary gland of transgenic mice. FEBS Letters. 319:181–184.
Eleouet, J.F., D. Rasschaert, P. Lambert, L. Levy, P. Vende, and H. Laude. 1995. Complete sequence (20 kilo-bases) of the polyprotein-encoding gene 1 of transmissible gastroenteritis virus. Virology. 206:817–822.
Enjuanes, L. and B.A.M. Van der Zeijst. 1995. Molecular basis of transmissible gastroenteritis coronavirus epidemiology. In The Coronaviridae. S.G. Siddell, editor. Plenum Press, New York. 337–376.
Esser, A.E, R.M. Bartholomew, F.C. Jensen, and H.J. Muller-Eberhardt. 1979. Disassembly of viral membranes by complement independent channel formation. Proc. Natl. Acad. Sci. USA. 76: 5843–5847.
Frolov, I. and S. Schlesinger. 1994. Translation of Sindbis virus mRNA: effect of sequences downstream of the initiation codon. J. Virol. 68:8111–8117.
Fujinami, R.S. and M.B.A. Oldstone. 1984. Antibody initiates virus persistence: immune modulation and measles virus infection. In Concepts in viral pathogenesis. A.L. Notkins and M.B.A. Oldstone, editors. Springer-Verlag, New York. 187–193.
Gebauer, F., W.A.P. Posthumus, I. Correa, C. Suné, C.M. Sánchez, C. Smerdou, J.A. Lenstra, R. Meloen, and L. Enjuanes. 1991. Residues involved in the formation of the antigenic sites of the S protein of transmissible gastroenteritis coronavirus. Virology. 183:225–238.
Guo, L., K.B. Lim, C.M. Poduje, M. Daniel, J.S. Gunn, M. Hackett, and S.I. Millers. 1998. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell. 95:189–198.
Habermann, E. and J. Jentsch. 1967. Sequence analysis of melittin from tryptic and peptic degradation products. Hoppe-Seyler’s Z. Physiol Chem. 348:37–50.
Hammer, M.C., P.J. Swart, M.-P. de Béthune, R. Pauwels, E.D. Clercq, T.H. The, and D.K.F. Meijer. 1995. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both guman immunodficiency virus and human cytomegalovirus replicaion in vitro. J. Infect. Dis. 172 :380–38
Hancock, R.E.W. 1997. Peptide antibiotics. Lancet. 349:418–422.
Izeta, A., C.M. Sanchez, C. Smerdou, A. Mendez, S. Alonso, M. Balasch, J. Plana-Duran, and L. Enjuanes. 1998. The spike protein of transmissible gastroenteritis coronavirus controls the tropism of pseudorecombinant virions engineered using synthetic minigenomes. Adv. Exp. Med. Biol. 440:207–21
Izeta, A., C. Smerdou, S. Alonso, Z. Penzes, A. Mendez, J. Plana-Duran, and L. Enjuanes. 1998b. Replication and packaging of transmissible gastroenteritis coronavirus derived synthetic minigenomes. J. Virol. 73: 1535–154
Jenuwein, T., W.C. Forrester, L.A. Fernández-Herrero, G. Laible, M. Dull, and R. Grosschedl. 1997. Extension of chromatin accessibility by nuclear matrix attachment regions. Nature. 385:269–27
Jones, S.D. and W.A. Marasco. 1997. Intracellular antibodies (intrabodies): potential applications in trans-genic animal research and engineered resistance to pathogens. In Transgenic animals. Generation and use. L.M. Houdebine, editor. Harwood Academic Publishers, Amsterdam. 501–506.
Kilian, M., J. Mestecky, and M.W. Russell. 1988. Defence mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by immunoglobulin A proteases. Microbio. Rev. 52:296–30
Kooyman, D.L. and C.A. Pinkert. 1994. Transgenic mice expressing a chimeric anti-E. coli immunoglobulin a heavy chain gene. Transgenic Res. 3:167–17
Lai, M.M.C and D. Cavanagh. 1997. The molecular biology of coronaviruses. Adv. Virus Res. 48:1–10
Lee, C.K., R. Weltzin, G. Soman, K.M. Georgakopoulos, D.M. Houle, and T.P. Monath. 1994. Oral administration of polymeric immunoglobulin A prevents colonization with vibrio cholerae in neonatal mice. Infec. Imm. 62:887–89
Lee, J.-Y. A. Boman, S. Chuanxin, M. Andersson, H. Jornvall, and V. Mutt. 1989. Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc. Natl. Acad. Sci. USA. 86:9159–9162.
Lee, S.H. and H.A. De Boer. 1994. Production of biomedical proteins in the milk of transgenic dairy cows: the state of the art. J. Cont. Release. 29:213–221.
Lehrer, R.I., T. Ganz, and M.E. Selsted. 1991. Defensins: endogenous antibiotic peptides of animal cells. Cell. 64:229–230.
Liljeström, P. 1994. Alphavirus expression systems. Curr. Opin. Biotech. 5:495–500.
Limonta, J., A. Pedraza, A. Rodriguez, F.M. Freyre, A.M. Barrai, F.O. Castro, R. Lleonart, C.A. Garcia, J.V. Gavilondo, and J. de la Fuente. 1995. Production of active anti-CD6 mouse-human chimeric antibodies in the milk of transgenic mice. Immunotechnology. 1:107–113.
Lo, D., V.G. Pursel, P.J. Linton, E. Sandgren, R. Behringer, C. Rexroad, R.D. Palmiter, and R.L. Brinster. 1991. Expression of mouse IgA by transgenic mice, pigs, and sheep. Eur. J. Immunol. 21:1001–1006.
Marasco, W.A., W.A. Haseltine, and S. Chen. 1993. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc. Natl. Acad. Sci. USA. 90:7889–7893.
Marcos, J.F., R.N. Beachy, R.A. Houghten, S.E. Blondelle, and E. Perez-Paya. 1995. Inhibition of plant virus infection by melittin. Proc. Natl. Acad. Sci. USA. 92:12466–12469.
Mazanec, M.B., C.L. Coudret, and D.R. Fletcher. 1995. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J. Virol. 69:1339–1343.
Mazanec, M.B., M.E. Lamm, D. Lyn, A. Portner, and J.G. Nedrud. 1992. Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract. Virus Res. 23:1–12.
Mazanec, M.B., J.G. Nedrud, C.S. Kaetzel, and M.E. Lamm. 1993. A three-tiered view of the role of IgA in mucosal defense. Immunol. Today. 14:430–434.
Mendez, A., C. Smerdou, A. Izeta, F. Gebauer, and L. Enjuanes. 1996. Molecular characterization of transmissible gastroenteritis coronavirus defective interfering genomes: Packaging and heterogeneity. Virology. 217:495–507.
Mestecky, J. and J.R. McGhee. 1987. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40:153–245.
Mhashilkar, A.M., J. Bagley, S.-Y. Chen, A.M. Szilvay, D.G. Heiland, and W.A. Marasco. 1995. Inhibition of HIV-1 tat-mediated LTR transactivation and HIV-1 infection by anti-tat single chain intrabodies. EMBO J. 14:1542–1551.
Muller, M. and G. Brem. 1994. Transgenic strategies to increase disease resistance in livestock. Repr. Fert. Develop. 6:605–613.
Muller, M. and G. Brem. 1996. Intracellular, genetic or congenital immunisation—transgenic approaches to increase disease resistance of farm animals. J. Biotechnol. 44:233–242.
Muller, M., U.H. Weidle, and G. Brem. 1997. Antibody encoding transgenes-their potential use in congenital and intracellular immunisation of farm animals. In Transgenic animals. Generation and use. L.M. Houdebine, editor. Harwood Academic Publishers, Amsterdam. 495–499.
Penzes, Z., J.M. Gonzalez, A. Izeta, M. Muntion, and L. Enjuanes. 1998. Progress towards the construction of a transmissible gastroenteritis coronavirus self-replicating RNA using a two-layer expression system. Adv. Exp. Med. Biol. 440:319–327.
Poljak, L., C. Seum, T. Mattioni, and U.K. Laemmli. 1994. SARs stimulate but do not confer position independent gene expression. Nucleic Acids Res. 22:4386–4394.
Pushko, P., M. Parker, G.V. Ludwing, N.L. Davis, R.E. Johnston, and J.F. Smith. 1997. Replication-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology. 239:389–401.
Reed, W.A., PH. Elzer, F.M. Enright, J.M. Jaynes, J.D. Morrey, and K.L. White. 1997. Interleukin 2 promoter/enhancer controlled expression of a synthetic cecropin-class lytic peptide in transgenic mice and subsequent resistance to Brucella abortus. Transgenic Res. 6:337–347
Renegar, K.B. and P.A. Small. 1991. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J. Virol. 65:2146–2148.
Richardson, J.H. and W.A. Marasco. 1995. Intracellular antibodies: development and therapeutic potential. TIBTECH. 13:306–310.
Saif, L.J. and R.D. Wesley. 1992. Transmissible gastroenteritis. In Diseases of Swine. A.D. Leman, B.E. Straw, W.L. Mengeling, S. D’Allaire, and D.J. Taylor, editors. Wolfe Publishing Ltd, Ames. Iowa. 362–386.
Sánchez, C.M., F. Gebauer, C. Suñé, A. Méndez, J. Dopazo, and L. Enjuanes. 1992. Genetic evolution and tropism of transmissible gastroenteritis coronaviruses. Virology. 190:92–105.
Sánchez, CM., G. Jiménez, M.D. Laviada, I. Correa, C. Suñé, M.J. Bullido, F. Gebauer, C. Smerdou, P. Callebaut, J.M. Escribano, and L. Enjuanes. 1990. Antigenic homology among coronaviruses related to transmissible gastroenteritis virus. Virology. 174:410–417.
Schanbacher, F.L., R.S. Talhouk, and FA. Murray. 1997. Biology and origin of bioactive peptides in milk. Lives. Prod. Sci. 50:105–123.
Smith, J.J., S.M. Travis, E.P. Greenberg, and M.J. Welsh. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell. 85:229–236.
Sola, I., J. Castilla, B. Pintado, J.M. Sánchez-Morgado, B. Whitelaw, J. Clark, and L. Enjuanes. 1998. Transgenic mice secreting coronavirus neutralizing antibodies into the milk. J. Virol. 72:3762–377
Steiner, H., D. Hultmark, A. Engstrom, H. Bennich, and H.G. Boman. 1981. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature. 292:246–248.
Storb, U. 1987. Transgenic mice with immunoglobulin genes. Ann. Rev. Immunol. 5:151–174.
Storb, U, C. Pinkert, B. Arp, P. Engler, K. Gollahon, J. Manz, W. Brady, and R.L. Brinster. 1986. Transgenic mice with μ and κ genes encoding antiphosphorylcholine antibodies. J. Exp. Med. 164:627–641.
Suñé, C., G. Jimenez, I. Correa, M.J. Bullido, F. Gebauer, C. Smerdou, and L. Enjuanes. 1990. Mechanisms of transmissible gastroenteritis coronavirus neutralization. Virology. 177:559–569.
Terwilliger, T.C and D. Eisenberg. 1982. The structure of melittin. II. Interpretation of the stucture. J. Biol. Chem. 257:6016–6022.
Torres, J.M., CM. Sánchez, C. Suñé, C. Smerdou, L. Prevec, F. Graham, and L. Enjuanes. 1995. Induction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein. Virology. 213:503–516.
VanCott, J.L.,T.A. Brim, J.K. Lunney, and L.J. Saif. 1994. Contribution of antibody-secreting cells induced in mucosal lymphoid tissues of pigs inoculated with respiratory or enteric strains of coronavirus to immunity against enteric coronavirus challenge. J. Immunol. 152:3980–3990.
Wachinger, M., A. Kleinschmidt, D. Winder, N. von Pechmann, A. Ludvigsen, M. Neumann, R. Holle, B. Salmons, V. Erfle, and R. Brack·Werner. 1998. Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. J. Gen. Virol. 79:731–740.
Wachinger, M., T. Saermark, and V. Erfle. 1992. Influence of amphipathic peptides on the HIV-1 production in persistently infected T-lymphoma cells. FEBS Letters. 309:235–341.
Wade, D., D. Andreu, S.A. Mitchell, A.M.V. Silveira, A. Boman, H.G. Boman, and R.B. Merrifield. 1992. Antibacterial peptides designed as analogs or hybrids of cecropins and melittin. Inter. J. Pept. Prot. Res. 40:429–436.
Weidle, U.H., H. Lenz, and G. Brem. 1991. Genes encoding a mouse monoclonal antibody are expressed in transgenic mice, rabbits, and pigs. Gene. 98:185–191.
Yarus, S., J.M. Rosen, A.M. Cole, and G. Diamond. 1996. Production of active bovine tracheal antimicrobial peptide in milk of transgenic mice. Proc. Natl. Acad. Sci. USA. 93:14118–14121.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Enjuanes, L. et al. (1999). Interference with Virus and Bacteria Replication by the Tissue Specific Expression of Antibodies and Interfering Molecules. In: Paul, P.S., Francis, D.H. (eds) Mechanisms in the Pathogenesis of Enteric Diseases 2. Advances in Experimental Medicine and Biology, vol 473. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4143-1_3
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4143-1_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6858-8
Online ISBN: 978-1-4615-4143-1
eBook Packages: Springer Book Archive